OCS: Oculis Holding AG Ordinary shares Stocks News on September 16, 2025

Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities

OCS

GlobeNewswire

7 days ago

Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities

OCS

GlobeNewswire

3 months ago

Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities

Oculis Publishes Results of 2025 Annual General Meeting

OCS

GlobeNewswire

3 months ago

Oculis Publishes Results of 2025 Annual General Meeting

OCS

GlobeNewswire

3 months ago

Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities

Oculis to Participate in Upcoming June Investor Conferences

OCS

GlobeNewswire

3 months ago

Oculis to Participate in Upcoming June Investor Conferences

Oculis Holding First Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags

OCS

Simply Wall St.

4 months ago

Oculis Holding First Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags

Oculis Publishes Invitation to the Annual General Meeting

OCS

GlobeNewswire

4 months ago

Oculis Publishes Invitation to the Annual General Meeting

Oculis Reports Q1 2025 Financial Results and Provides Company Update

OCS

GlobeNewswire

4 months ago

Oculis Reports Q1 2025 Financial Results and Provides Company Update

Oculis Reports Q1 Financial Results and Provides Company Update

OCS

GlobeNewswire

4 months ago

Oculis Reports Q1 Financial Results and Provides Company Update

Oculis to Present at Upcoming May Investor Conferences

OCS

GlobeNewswire

4 months ago

Oculis to Present at Upcoming May Investor Conferences

Oculis to Present its Innovative Late-Stage Pipeline Candidates at Upcoming Ophthalmology Conferences

OCS

GlobeNewswire

5 months ago

Oculis to Present its Innovative Late-Stage Pipeline Candidates at Upcoming Ophthalmology Conferences

OCS

GlobeNewswire

5 months ago

Oculis Updates Share Capital

Oculis and EURETINA Announce the 2025 Ramin Tadayoni Award

OCS

GlobeNewswire

5 months ago

Oculis and EURETINA Announce the 2025 Ramin Tadayoni Award

Oculis Hosts R&D Event Today to Showcase Progress on All Three Pipeline Assets

OCS

GlobeNewswire

5 months ago

Oculis Hosts R&D Event Today to Showcase Progress on All Three Pipeline Assets

Oculis Completes Enrollment in both DIAMOND Phase 3 Trials of OCS-01 in Diabetic Macular Edema

OCS

GlobeNewswire

5 months ago

Oculis Completes Enrollment in both DIAMOND Phase 3 Trials of OCS-01 in Diabetic Macular Edema

OCS

GlobeNewswire

5 months ago

Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities

Oculis to Host In-Person and Virtual R&D Day on Key Business Updates and the Development Plans for Privosegtor (OCS-05) in Acute Optic Neuritis and Beyond

OCS

GlobeNewswire

5 months ago

Oculis to Host In-Person and Virtual R&D Day on Key Business Updates and the Development Plans for Privosegtor (OCS-05) in Acute Optic Neuritis and Beyond

Oculis Publishes Notifications of Transactions by Person Discharging Managerial Responsibilities

OCS

GlobeNewswire

6 months ago

Oculis Publishes Notifications of Transactions by Person Discharging Managerial Responsibilities

Lionel Carnot Spends CHF326k On Oculis Holding Stock

OCS

Simply Wall St.

6 months ago

Lionel Carnot Spends CHF326k On Oculis Holding Stock

OCS

GlobeNewswire

6 months ago

Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities

Oculis Holding Full Year 2024 Earnings: Misses Expectations

OCS

Simply Wall St.

6 months ago

Oculis Holding Full Year 2024 Earnings: Misses Expectations

Oculis Reports Q4 and Full Year 2024 Financial Results and Provides Company Update

OCS

GlobeNewswire

6 months ago

Oculis Reports Q4 and Full Year 2024 Financial Results and Provides Company Update

Oculis to Present at Upcoming March Investor Conference

OCS

GlobeNewswire

6 months ago

Oculis to Present at Upcoming March Investor Conference

OCS

GlobeNewswire

6 months ago

Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities

Oculis Announces Pricing of $100 Million Oversubscribed Offering of Ordinary Shares

OCS

GlobeNewswire

7 months ago

Oculis Announces Pricing of $100 Million Oversubscribed Offering of Ordinary Shares

Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities and Persons Closely Associated

OCS

GlobeNewswire

7 months ago

Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities and Persons Closely Associated

We're Hopeful That Oculis Holding (NASDAQ:OCS) Will Use Its Cash Wisely

OCS

Simply Wall St.

7 months ago

We're Hopeful That Oculis Holding (NASDAQ:OCS) Will Use Its Cash Wisely

Oculis updates share capital for its existing at-the-market offering program

OCS

GlobeNewswire

8 months ago

Oculis updates share capital for its existing at-the-market offering program

Oculis Publishes Notification of Major Changes in Voting Rights

OCS

GlobeNewswire

8 months ago

Oculis Publishes Notification of Major Changes in Voting Rights

OCS

GlobeNewswire

8 months ago

Oculis Publishes Notification of Major Changes in Voting Rights

Oculis Trial Shows Potential for Optical Neuroprotective Therapy

OCS

Exec Edge

8 months ago

Oculis Trial Shows Potential for Optical Neuroprotective Therapy

Oculis Announces Positive OCS-05 Phase 2 ACUITY Trial in Acute Optic Neuritis, Met Primary Safety Endpoint and Key Secondary Efficacy Endpoints Opening Development Pathways as a Potential First-in-Class Neuroprotective Therapy

OCS

GlobeNewswire

8 months ago

Oculis Announces Positive OCS-05 Phase 2 ACUITY Trial in Acute Optic Neuritis, Met Primary Safety Endpoint and Key Secondary Efficacy Endpoints Opening Development Pathways as a Potential First-in-Class Neuroprotective Therapy

OCS

GlobeNewswire

8 months ago

Oculis Publishes Notification of Major Changes in Voting Rights

OCS

GlobeNewswire

9 months ago

Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities

OCS

GlobeNewswire

10 months ago

Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities and Persons Closely Associated

Oculis Publishes Notification of Transaction by Person Discharging Managerial Responsibilities

OCS

GlobeNewswire

10 months ago

Oculis Publishes Notification of Transaction by Person Discharging Managerial Responsibilities

Oculis to Present at the Stifel 2024 Healthcare Conference

OCS

GlobeNewswire

10 months ago

Oculis to Present at the Stifel 2024 Healthcare Conference

OCS

GlobeNewswire

10 months ago

Oculis to Present at the Stifel 2024 Healthcare Conference

Oculis Holding Third Quarter 2024 Earnings: Misses Expectations

OCS

Simply Wall St.

10 months ago

Oculis Holding Third Quarter 2024 Earnings: Misses Expectations

Oculis Reports Q3 2024 Financial Results and Provides Company Updates

OCS

GlobeNewswire

10 months ago

Oculis Reports Q3 2024 Financial Results and Provides Company Updates

Oculis Holding AG's (NASDAQ:OCS) largest shareholders are individual investors with 56% ownership, institutions own 39%

OCS

Simply Wall St.

a year ago

Oculis Holding AG's (NASDAQ:OCS) largest shareholders are individual investors with 56% ownership, institutions own 39%

Oculis Accelerates Enrollment in both DIAMOND Phase 3 Trials of OCS-01 in Diabetic Macular Edema and Expands its DIAMOND Program Committees

OCS

GlobeNewswire

a year ago

Oculis Accelerates Enrollment in both DIAMOND Phase 3 Trials of OCS-01 in Diabetic Macular Edema and Expands its DIAMOND Program Committees

OCS

GlobeNewswire

a year ago

Oculis Accelerates Enrollment in both DIAMOND Phase 3 Trials of OCS-01 in Diabetic Macular Edema and Expands its DIAMOND Program Committees

Oculis’ DIAMOND Phase 3 Program in Diabetic Macular Edema to be Presented at Innovate Retina and Eyecelerator 2024

OCS

GlobeNewswire

a year ago

Oculis’ DIAMOND Phase 3 Program in Diabetic Macular Edema to be Presented at Innovate Retina and Eyecelerator 2024

Oculis Announces Appointment of Daniel S. Char as Chief Legal Officer

OCS

GlobeNewswire

a year ago

Oculis Announces Appointment of Daniel S. Char as Chief Legal Officer

Oculis and EURETINA Announce the Winner of the Inaugural Ramin Tadayoni Award

OCS

GlobeNewswire

a year ago

Oculis and EURETINA Announce the Winner of the Inaugural Ramin Tadayoni Award

Oculis Holding (NASDAQ:OCS) Is In A Good Position To Deliver On Growth Plans

OCS

Simply Wall St.

a year ago

Oculis Holding (NASDAQ:OCS) Is In A Good Position To Deliver On Growth Plans

Oculis to Present at Upcoming September Investor Conferences

OCS

GlobeNewswire

a year ago

Oculis to Present at Upcoming September Investor Conferences

Oculis Publishes Consolidated Q2 Financial Statements and MD&A

OCS

GlobeNewswire

a year ago

Oculis Publishes Consolidated Q2 Financial Statements and MD&A

Oculis Reports Q2 Financial Results and Provides Recent Company Update

OCS

GlobeNewswire

a year ago

Oculis Reports Q2 Financial Results and Provides Recent Company Update

Oculis Reports Q2 2024 Financial Results and Provides Recent Company Update

OCS

GlobeNewswire

a year ago

Oculis Reports Q2 2024 Financial Results and Provides Recent Company Update

Oculis Appoints Sharon Klier, M.D., M.S., M.P.H. as Chief Development Officer

OCS

GlobeNewswire

a year ago

Oculis Appoints Sharon Klier, M.D., M.S., M.P.H. as Chief Development Officer

Oculis to Participate in the H.C. Wainwright 4th Annual Ophthalmology Virtual Conference

OCS

GlobeNewswire

a year ago

Oculis to Participate in the H.C. Wainwright 4th Annual Ophthalmology Virtual Conference

Oculis and EURETINA Announces the Ramin Tadayoni Award

OCS

GlobeNewswire

a year ago

Oculis and EURETINA Announces the Ramin Tadayoni Award

Hyundai Motor Presents Its First Film 'Night Fishing' in Collaboration with K-Movie Star Son Sukku

OCS

CNW Group

a year ago

Hyundai Motor Presents Its First Film 'Night Fishing' in Collaboration with K-Movie Star Son Sukku

HEATHERWICK STUDIO UNVEILS ICONIC GLASS CANOPY, THE JEWEL IN THE CROWN OF REIMAGINED OLYMPIA

OCS

CNW Group

a year ago

HEATHERWICK STUDIO UNVEILS ICONIC GLASS CANOPY, THE JEWEL IN THE CROWN OF REIMAGINED OLYMPIA

IMAGO AIOS Prime Clinches Red Dot Award for 2024, Expands US Footprint with New Boston Warehouse

OCS

PR Newswire

a year ago

IMAGO AIOS Prime Clinches Red Dot Award for 2024, Expands US Footprint with New Boston Warehouse

Seibu Ikebukuro Main Store Slated for Summer 2025 Grand Re-opening as a New Department Store

OCS

Business Wire

a year ago

Seibu Ikebukuro Main Store Slated for Summer 2025 Grand Re-opening as a New Department Store

New Zealand scraps plan to tax livestock burps, farts

OCS

AFP

a year ago

New Zealand scraps plan to tax livestock burps, farts

ECB’s Lagarde Sees Multi-Meeting Rate Holds A Possibility

OCS

The Wall Street Journal

a year ago

ECB’s Lagarde Sees Multi-Meeting Rate Holds A Possibility

OCS

Business Wire

a year ago

InnoCare Announces Clearance of Clinical Trial of TYK2 Inhibitor ICP-332 by U.S. FDA

UK Unemployment Rises in Sign Inflationary Pressures Cool

OCS

Bloomberg

a year ago

UK Unemployment Rises in Sign Inflationary Pressures Cool

Oculis Announces Positive Topline Results of Phase 2b RELIEF Trial with Licaminlimab, Designed to Transform the Treatment Paradigm of Dry Eye Disease with a Precision Medicine Strategy

OCS

GlobeNewswire

a year ago

Oculis Announces Positive Topline Results of Phase 2b RELIEF Trial with Licaminlimab, Designed to Transform the Treatment Paradigm of Dry Eye Disease with a Precision Medicine Strategy

OCS

GlobeNewswire

a year ago

Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities

Oculis Publishes Results of 2024 Annual General Meeting and Announces Appointments to its Board of Directors and Scientific Advisory Board

OCS

GlobeNewswire

a year ago

Oculis Publishes Results of 2024 Annual General Meeting and Announces Appointments to its Board of Directors and Scientific Advisory Board

While institutions own 39% of Oculis Holding AG (NASDAQ:OCS), individual investors are its largest shareholders with 55% ownership

OCS

Simply Wall St.

a year ago

While institutions own 39% of Oculis Holding AG (NASDAQ:OCS), individual investors are its largest shareholders with 55% ownership

OCS

GlobeNewswire

a year ago

Oculis updates share capital for its existing at-the-market offering program

Oculis Reports Q1 2024 Financial Results and Provides Company Updates

OCS

GlobeNewswire

a year ago

Oculis Reports Q1 2024 Financial Results and Provides Company Updates

OCS

GlobeNewswire

a year ago

Oculis Reports Q1 2024 Financial Results and Provides Company Updates

Oculis Announces Completion of Enrollment in Phase 2 Randomized Controlled ACUITY Trial with OCS-05 for Acute Optic Neuritis

OCS

GlobeNewswire

a year ago

Oculis Announces Completion of Enrollment in Phase 2 Randomized Controlled ACUITY Trial with OCS-05 for Acute Optic Neuritis

OCS

GlobeNewswire

a year ago

Oculis Publishes Invitation to the Annual General Meeting

Oculis to Present at Bank of America Global Healthcare Conference

OCS

GlobeNewswire

a year ago

Oculis to Present at Bank of America Global Healthcare Conference

OCS

GlobeNewswire

a year ago

Oculis Publishes Invitation to the Annual General Meeting

Oculis Announces Closing of Registered Direct Offering and Commencement of Trading on Nasdaq Iceland Main Market

OCS

GlobeNewswire

a year ago

Oculis Announces Closing of Registered Direct Offering and Commencement of Trading on Nasdaq Iceland Main Market

Oculis Announces Completion of Oversubscribed $59 Million Registered Direct Offering and Subsequent Listing on Nasdaq Iceland Main Market

OCS

GlobeNewswire

a year ago

Oculis Announces Completion of Oversubscribed $59 Million Registered Direct Offering and Subsequent Listing on Nasdaq Iceland Main Market

Oculis Strengthens its Executive Leadership Team with the Appointment of Snehal Shah, Pharm.D. as President of Research & Development

OCS

GlobeNewswire

a year ago

Oculis Strengthens its Executive Leadership Team with the Appointment of Snehal Shah, Pharm.D. as President of Research & Development

$Positive Results from Phase 3 OPTIMIZE-1 Trial of Once Daily OCS-01 for the Treatment of Inflammation and Pain Following Cataract Surgery Presented at the 2024 American Society of Cataract and Refractive Surgery Annual Meeting$

OCS

GlobeNewswire

a year ago

Positive Results from Phase 3 OPTIMIZE-1 Trial of Once Daily OCS-01 for the Treatment of Inflammation and Pain Following Cataract Surgery Presented at the 2024 American Society of Cataract and Refractive Surgery Annual Meeting

Oculis to Participate at Upcoming April Investor Conferences

OCS

GlobeNewswire

a year ago

Oculis to Participate at Upcoming April Investor Conferences

Oculis Reports Q4 and Full Year 2023 Financial Results and Update on Company Progress

OCS

GlobeNewswire

a year ago

Oculis Reports Q4 and Full Year 2023 Financial Results and Update on Company Progress

Oculis Provides Updates at R&D Day on Late-Stage Clinical Trials and Announces Key Leadership Appointments

OCS

GlobeNewswire

2 years ago

Oculis Provides Updates at R&D Day on Late-Stage Clinical Trials and Announces Key Leadership Appointments

Oculis to Present at Upcoming February Investor Conferences

OCS

GlobeNewswire

2 years ago

Oculis to Present at Upcoming February Investor Conferences

Horizon Bancorp, Inc. (NASDAQ:HBNC) Q4 2023 Earnings Call Transcript

OCS

Insider Monkey

2 years ago

Horizon Bancorp, Inc. (NASDAQ:HBNC) Q4 2023 Earnings Call Transcript

Down -15.09% in 4 Weeks, Here's Why You Should You Buy the Dip in CureVac N.V. (CVAC)

OCS

Zacks

2 years ago

Down -15.09% in 4 Weeks, Here's Why You Should You Buy the Dip in CureVac N.V. (CVAC)

Obsidian Energy Announces 2024 Guidance With 12 Percent Growth in Average Annual Production to 36,000 boe/d

OCS

Newsfile

2 years ago

Obsidian Energy Announces 2024 Guidance With 12 Percent Growth in Average Annual Production to 36,000 boe/d

Washington Trust Bancorp (WASH) Surpasses Q4 Earnings Estimates

OCS

Zacks

2 years ago

Washington Trust Bancorp (WASH) Surpasses Q4 Earnings Estimates

Brookline Bancorp Inc (BRKL) Reports Mixed Fourth Quarter Results Amidst Industry Headwinds

OCS

GuruFocus.com

2 years ago

Brookline Bancorp Inc (BRKL) Reports Mixed Fourth Quarter Results Amidst Industry Headwinds

OCS

GuruFocus.com

2 years ago

HomeTrust Bancshares Inc Reports Mixed Quarterly Results Amid Strategic Changes

Core Laboratories (CLB) Reports Next Week: What You Should Expect

OCS

Zacks

2 years ago

Core Laboratories (CLB) Reports Next Week: What You Should Expect

OCS

Associated Press Finance

2 years ago

HomeTrust Bancshares: Fiscal Q2 Earnings Snapshot

HomeTrust Bancshares, Inc. Announces Financial Results for the Second Quarter of the Six-Month Transition Period Ending December 31, 2023* and Quarterly Dividend

OCS

GlobeNewswire

2 years ago

HomeTrust Bancshares, Inc. Announces Financial Results for the Second Quarter of the Six-Month Transition Period Ending December 31, 2023* and Quarterly Dividend

Bitdeer Named One of Singapore’s Fastest Growing Companies 2024

OCS

GlobeNewswire

2 years ago

Bitdeer Named One of Singapore’s Fastest Growing Companies 2024

The past three years for Cantaloupe (NASDAQ:CTLP) investors has not been profitable

OCS

Simply Wall St.

2 years ago

The past three years for Cantaloupe (NASDAQ:CTLP) investors has not been profitable

Oculis to Host In-Person & Virtual R&D Day in New York on February 28, 2024

OCS

GlobeNewswire

2 years ago

Oculis to Host In-Person & Virtual R&D Day in New York on February 28, 2024

Daily Journal (NASDAQ:DJCO) Might Have The Makings Of A Multi-Bagger

OCS

Simply Wall St.

2 years ago

Daily Journal (NASDAQ:DJCO) Might Have The Makings Of A Multi-Bagger

Berry Corporation Releases Select Preliminary 2023 Results and Schedules Fourth Quarter and Full Year 2023 Earnings Release and Conference Call for March 6

OCS

GlobeNewswire

2 years ago

Berry Corporation Releases Select Preliminary 2023 Results and Schedules Fourth Quarter and Full Year 2023 Earnings Release and Conference Call for March 6

Why Earnings Season Could Be Great for Business First (BFST)

OCS

Zacks

2 years ago

Why Earnings Season Could Be Great for Business First (BFST)

When Will Remitly Global, Inc. (NASDAQ:RELY) Turn A Profit?

OCS

Simply Wall St.

2 years ago

When Will Remitly Global, Inc. (NASDAQ:RELY) Turn A Profit?

Cantaloupe, Inc. to Report Second Quarter Fiscal Year 2024 Results on February 8, 2024

OCS

Business Wire

2 years ago

Cantaloupe, Inc. to Report Second Quarter Fiscal Year 2024 Results on February 8, 2024

Why You Should Retain Elevance (ELV) Stock in Your Portfolio

OCS

Zacks

2 years ago

Why You Should Retain Elevance (ELV) Stock in Your Portfolio

Cerence and Škoda Elevate the In-Vehicle Experience with Cerence Chat Pro

OCS

GlobeNewswire

2 years ago

Latest Oculis Holding AG Ordinary shares (OCS) News on September 16, 2025

Share on Social Networks: